Founder and CEO, Lighter Capital
Founder and CEO of Brooks Bell Inc.
Chair, Department of Chemical Physiology, The Scripps Research Institute; Co-director, Center for Physiological Proteomics, The Scripps Research Institute
Pharmacological research reveals that marine cyanobacteria, single-celled organisms often referred to as blue-green algae, are an effective cancer treatment. Combining cyanobacteria with new screening processes and technology is openingh a new frontier in in anticancer and anti-inflammatory research that is rich with opportunities. Cyanobacteria and algae are especially rich in lipids that are being studied for their usefulness in creating renewable biofuels. More information and online registration is available here.